Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2025-12-24 @ 1:32 PM
NCT ID:
NCT03359395
Eligibility Criteria:
Inclusion Criteria:
* Age \> /=18 years
* Males or females
* Anticipating electroconvulsive therapy to treat refractory depressive disorder
Exclusion Criteria:
* Under the age of 18
* Allergy to alfentanil
* Allergy to other standard anesthetic medications utilized in the course of ECT (glycopyrrolate, methohexital, and succinylcholine)
* History of malignant hyperthermia
* History of severe airway obstruction, bronchospasm or laryngospasm
* History of recent myocardial infarction, ventricular arrhythmia
* Adverse reaction to ECT requiring premedication with lidocaine or atropine
* Non-English speaking
* Patients unable to consent for themselves
* Current pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03359395
Study Brief:
Protocol Section:
NCT03359395